1. 525 Safety and efficacy of pembrolizumab (MK-3475) in patients (pts) with advanced biliary tract cancer: Interim results of KEYNOTE-028. (September 2015) Authors: Bang, Y.J.; Doi, T.; Braud, F. De; Piha-Paul, S.; Hollebecque, A.; Razak, A.R. Abdul; Lin, C.C.; Ott, P.A.; He, A.R.; Yuan, S.S.; Koshiji, M.; Lam, B.; Aggarwal, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Hox Family-Based Scoring System Predicts the Clinical Outcome of Myelodysplastic Syndromes. (April 2017) Authors: Yao, C.Y.; Lin, C.C.; Hou, H.A.; Kao, C.J.; Tseng, M.H.; Chou, W.C.; Tien, H.F. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Abstract P-548: POINT-OF-CARE ECHOCARDIOGRAPHY IN NEONATAL INTENSIVE CARE UNIT. (June 2018) Authors: Hsieh, K.S.; Lin, C.C. Journal: Pediatric critical care medicine Issue: Volume 19(2018)Supplement 1 6 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Abstract P-549: POINT-OF-CARE ECHOCARDIOGRAPHY IN PEDIATRIC INTENSIVE CARE UNIT. (June 2018) Authors: Hsieh, K.S.; Lin, C.C. Journal: Pediatric critical care medicine Issue: Volume 19(2018)Supplement 1 6 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Abstract PCCLB-65: Reappraisal of electrocardiographic changes in pediatric patients with acute myocarditis. (June 2018) Authors: Chen, Y.C.; Weng, K.P.; Lin, C.C.; Hsieh, K.S. Journal: Pediatric critical care medicine Issue: Volume 19(2018)Supplement 1 6 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. An intention-to-treat competing-risk model for candidates with hepatocellular cancer waiting for liver transplantation. (February 2019) Authors: Lai, Q.; Cucchetti, A.; Vitale, A.; Halazun, K.; Iesari, S.; Lehner, K.; Bhangui, P.; Mennini, G.; Wong, T.; Kaido, T.; Lin, C.C.; Hoppe-Lotichius, M.; Ikegami, T.; Xie, Q.F.; Zhe, Y.; Zheng, S.S.; Soejima, Y.; Otto, G.; Chen, C.L.; Uemoto, S. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Biocompatibility of a fish scale-derived artificial cornea: Cytotoxicity, cellular adhesion and phenotype, and in vivo immunogenicity. (March 2016) Authors: van Essen, T.H.; van Zijl, L.; Possemiers, T.; Mulder, A.A.; Zwart, S.J.; Chou, C.-H.; Lin, C.C.; Lai, H.J.; Luyten, G.P.M.; Tassignon, M.J.; Zakaria, N.; El Ghalbzouri, A.; Jager, M.J. Journal: Biomaterials Issue: Volume 81(2016) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Biocompatibility of a fish scale-derived artificial cornea: Cytotoxicity, cellular adhesion and phenotype, and in vivo immunogenicity. (March 2016) Authors: van Essen, T.H.; van Zijl, L.; Possemiers, T.; Mulder, A.A.; Zwart, S.J.; Chou, C.-H.; Lin, C.C.; Lai, H.J.; Luyten, G.P.M.; Tassignon, M.J.; Zakaria, N.; El Ghalbzouri, A.; Jager, M.J. Journal: Biomaterials Issue: Volume 81(2016) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Change in symptom clusters in head and neck cancer patients undergoing postoperative radiotherapy: A longitudinal study. (August 2018) Authors: Chiang, S.H.; Ho, K.Y.; Wang, S.Y.; Lin, C.C. Journal: European journal of oncology nursing Issue: Volume 35(2018) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Continuous vs intermittent adenosine 2A receptor (A2AR) inhibition in preclinical colon cancer (CC) models and in a Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients (pts) with non-small cell lung cancer (NSCLC). (October 2020) Authors: Lin, C.C.; Joerger, M.; Grell, P.; Chiappori, A.A.; Leal, T.A.; Kasper, S.; Jerusalem, G.; Gonçalves, A.; Wolf, J.; De Braud, F.; de Jonge, M.J.A.; Otero, J.; Chhagan, S.; Cipolletta, D.; Morris, E.; Chowdhury, N.R.; Hurtado, F.K.; Tan, D.S. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗